A study to determine the usual disease course of myotubular myopathy has sites in North America and France
posted on March 18, 2014 - 11:41am
Update (May 20, 2014): This story has been updated to reflect additional information received May 20, 2014, from Michelle Nelken at Valerion Therapeutics, including the joint sponsorship of this study by Valerion and Genethon.
A privacy-protected registry and global map using geographic tagging of people with centronuclear/myotubular myopathy is being developed to speed research
posted on October 31, 2013 - 3:23pm
A patient registry and world map of people with centronuclear myopathies (CNM), including myotubular myopathy (MTM), are being developed and are seeking participation from people with these disorders or their family members.